4//SEC Filing
Kirchgraber Paul R 4
Accession 0001127602-23-004109
CIK 0000920148other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 12:02 PM ET
Size
7.9 KB
Accession
0001127602-23-004109
Insider Transaction Report
Form 4
Kirchgraber Paul R
CEO, Covance Drug Development
Transactions
- Award
Non-qualified Stock Options
2023-02-07+5,000→ 5,000 totalExercise: $247.24From: 2024-02-07Exp: 2033-02-06→ Common Stock (5,000 underlying) - Award
Restricted Stock Unit
2023-02-07+1,590→ 3,484 total→ Common Stock (1,590 underlying)
Footnotes (5)
- [F1]Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
- [F2]The Restricted Stock Units vest in three equal annual installments beginning on February 7, 2024.
- [F3]This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
- [F4]Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
- [F5]The option vests in three equal annual installments beginning on the date reflected in this column.
Documents
Issuer
LABORATORY CORP OF AMERICA HOLDINGS
CIK 0000920148
Entity typeother
Related Parties
1- filerCIK 0001791393
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 12:02 PM ET
- Size
- 7.9 KB